Although all of these aforementioned studies concluded that Ki-67 can be an important biomarker for proliferation and survival in GBM, even in the preoperative settings [148], other studies did not find any correlation with prognosis [137,149,150], so its role as a prognostic factor is still debated. The gene discussed is MKI67; the disease is glioblastoma.